1. Home
  2. BCYC vs TMCI Comparison

BCYC vs TMCI Comparison

Compare BCYC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • TMCI
  • Stock Information
  • Founded
  • BCYC 2009
  • TMCI 2014
  • Country
  • BCYC United Kingdom
  • TMCI United States
  • Employees
  • BCYC N/A
  • TMCI N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BCYC Health Care
  • TMCI Health Care
  • Exchange
  • BCYC Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • BCYC 620.7M
  • TMCI 516.6M
  • IPO Year
  • BCYC 2019
  • TMCI 2021
  • Fundamental
  • Price
  • BCYC $8.56
  • TMCI $8.32
  • Analyst Decision
  • BCYC Buy
  • TMCI Hold
  • Analyst Count
  • BCYC 8
  • TMCI 8
  • Target Price
  • BCYC $29.14
  • TMCI $9.00
  • AVG Volume (30 Days)
  • BCYC 331.4K
  • TMCI 389.9K
  • Earning Date
  • BCYC 05-01-2025
  • TMCI 05-06-2025
  • Dividend Yield
  • BCYC N/A
  • TMCI N/A
  • EPS Growth
  • BCYC N/A
  • TMCI N/A
  • EPS
  • BCYC N/A
  • TMCI N/A
  • Revenue
  • BCYC $35,275,000.00
  • TMCI $209,357,000.00
  • Revenue This Year
  • BCYC N/A
  • TMCI $10.86
  • Revenue Next Year
  • BCYC $18.29
  • TMCI $10.06
  • P/E Ratio
  • BCYC N/A
  • TMCI N/A
  • Revenue Growth
  • BCYC 30.76
  • TMCI 11.88
  • 52 Week Low
  • BCYC $8.20
  • TMCI $3.92
  • 52 Week High
  • BCYC $28.67
  • TMCI $13.24
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 29.39
  • TMCI 44.87
  • Support Level
  • BCYC $8.60
  • TMCI $8.34
  • Resistance Level
  • BCYC $9.69
  • TMCI $8.87
  • Average True Range (ATR)
  • BCYC 0.67
  • TMCI 0.42
  • MACD
  • BCYC 0.00
  • TMCI 0.05
  • Stochastic Oscillator
  • BCYC 6.05
  • TMCI 56.25

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: